Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study

This study is a Delphi-based expert consensus project designed to establish evidence-informed, practical recommendations for the use of isotretinoin in acne vulgaris. Despite isotretinoin being the most effective therapy for severe and refractory acne, variations persist in its indications, dosing strategies, monitoring protocols, and safety counseling.

NCT Number	NCT07296523
Lead Sponsor	Venus Research Center
Conditions	Isotretinoin, Isotretinoin Adverse Reaction, Acne
Enrollment	15 participants
Start Date	2026-01-25
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-22